7.00% p.a. Early Redemption Worst of GOAL

Underlying: GlaxoSmithKline / Novartis / Roche SSPA/EUSIPA Product Type: Reverse Convertibles (1220) Valor: 52164275 / ISIN: CH0521642758

Last update 15:45:26
  • Bid

    97.28 %
    Volume: 100'000

  • Ask

    98.28 %
    Volume: 100'000